VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
39 hedge funds and large institutions have $182M invested in Verona Pharma in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.62%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
4
Increased
9
Reduced
4
Closed
7
Calls
$79K
Puts
–
Net Calls
+$79K
Net Calls Change
+$476K
Top Buyers
1 |
Citigroup
New York
|
+$1.84M |
2 |
LGM
Logos Global Management
San Francisco,
California
|
+$888K |
3 |
PA
Perceptive Advisors
New York
|
+$882K |
4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$66K |
5 |
Millennium Management
New York
|
+$54.2K |